A Johnson & Johnson executive joins the advisory team at Nice Company.
2 reports, 1 independent
Updated Aug 12
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A Johnson & Johnson executive joins the advisory team at Nice Company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
Christopher Gavigan
American entrepreneur
Nothing else this week.
Related events
- Johnson & Johnson was referenced in a recent news report concerning New York City.
- Institutional investors boosted their stake in Johnson & Johnson (JNJ) shares, highlighting the company's drug profits and balance sheet in filings with the SEC.
- A fund trimmed its position in Johnson & Johnson (JNJ) stock and disclosed the transaction via financial filings with the SEC.